Back
State Street Financial Sel Sec SPDR ETF Vs. Oruka Therapeutics, Inc. Industry Stock Comparison
Buy
70
XLF
State Street Financial Sel Sec SPDR ETF
Last Price:
$55.45
Seasonality Move:
0.54%
Sell
40
ORKA
Oruka Therapeutics, Inc.
Last Price:
$32.34
Seasonality Move:
-10.99%
Buy
70
State Street Financial Sel Sec SPDR ETF (XLF)
is a Buy
Is State Street Financial Sel Sec SPDR ETF a Buy, Sell or Hold?
-
The current State Street Financial Sel Sec SPDR ETF [XLF] share price is $55.32. The Score for XLF is 70, which is 40% above its historic median score of 50, and infers lower risk than normal.
-
XLF is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Sell
40
Oruka Therapeutics, Inc. (ORKA)
is a Sell
Is Oruka Therapeutics, Inc. a Buy, Sell or Hold?
-
The current Oruka Therapeutics, Inc. [ORKA] share price is $31.97. The Score for ORKA is 40, which is 20% below its historic median score of 50, and infers higher risk than normal.
-
ORKA is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
XLF Stock Price Chart
What is State Street Financial Sel Sec SPDR ETF's stock price today?
-
The State Street Financial Sel Sec SPDR ETF share price today is $55.32Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and XLF is experiencing buying pressure, which is a positive indicator for future bullish movement.
ORKA Stock Price Chart
What is Oruka Therapeutics, Inc.'s stock price today?
-
The Oruka Therapeutics, Inc. share price today is $31.97Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and ORKA is experiencing slight buying pressure.
XLF Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 12.21 | Buy |
| Relative Strength Index (14 RSI): | 68.4 | Buy |
| Chaikin Money Flow: | 24963392 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (52.08 - 54.64) | Buy |
| Bollinger Bands (100): | (52.19 - 54.01) | Buy |
ORKA Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.74 | Buy |
| Relative Strength Index (14 RSI): | 61.53 | Buy |
| Chaikin Money Flow: | 394649 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (28.23 - 31.09) | Buy |
| Bollinger Bands (100): | (15.89 - 28.91) | Buy |
XLF Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 54.85 | Buy |
| 20-day SMA: | 53.84 | Buy |
| 50-day SMA: | 53.03 | Buy |
| 200-day SMA: | 51.6 | Buy |
| 8-day EMA: | 34.82 | Buy |
| 20-day EMA: | 18.1 | Buy |
| 50-day EMA: | 8.11 | Buy |
| 200-day EMA: | 2.15 | Buy |
ORKA Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 29.97 | Buy |
| 20-day SMA: | 30.06 | Buy |
| 50-day SMA: | 28.52 | Buy |
| 200-day SMA: | 16.89 | Buy |
| 8-day EMA: | 30.34 | Buy |
| 20-day EMA: | 29.78 | Buy |
| 50-day EMA: | 27.54 | Buy |
| 200-day EMA: | 21.05 | Buy |
State Street Financial Sel Sec SPDR ETF Earnings Growth & XLF Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
Oruka Therapeutics, Inc. Earnings Growth & ORKA Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.18 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.63 per share, and a decrease next year of $0.32 per share.
State Street Financial Sel Sec SPDR ETF Technical Analysis
| Dec 9 | Dec 10 | Dec 11 | Dec 12 | Dec 15 | Dec 16 | Dec 17 | Dec 18 | Dec 19 | Dec 22 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec | ||||||||||
| 09 | 10 | 11 | 12 | 15 | 16 | 17 | 18 | 19 | 22 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Oruka Therapeutics, Inc. Technical Analysis
| Dec 9 | Dec 10 | Dec 11 | Dec 12 | Dec 15 | Dec 16 | Dec 17 | Dec 18 | Dec 19 | Dec 22 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec | ||||||||||
| 09 | 10 | 11 | 12 | 15 | 16 | 17 | 18 | 19 | 22 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||